Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Machaon who wrote (23478)	7/24/1998 12:50:00 PM
From: Mudcat	Read Replies (1) \| Respond to of 32384

< Ligand's $500 million cap might seem fairly priced, or, perhaps, a little expensive, but when you look at the total picture, it is cheap.> Robert, you appear to be learning quite well to be a master of spin from Henry. In your statement above you claim Ligand is 1. fairly priced 2. a little expensive and 3. cheap, and all in one sentence. So six months from now you will do like Henry does and say I told you six months ago ....: Price scenarios six months from now and what you will claim: 11 1/2 I told you six months ago Ligand was fairly priced. 9 I told you six months ago Ligand was a little expensive. 17 I told you six months ago Ligand was cheap. The sidekick is becoming a junior spin master. LOL